Assenagon Asset Management
TARO

Assenagon Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Assenagon Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,727
Closed -$432K – 969
2019
Q3 		$432K Hold
5,727
– – ﹤0.01% 721
2019
Q2 		$489K Buy
+5,727
New +$566K ﹤0.01% 858

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Assenagon Asset Management's TARO Position: Q4 2019 in Review

Assenagon Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 5,727 shares — an estimated $432K sold.

Assenagon Asset Management first reported a position in TARO in Q2 2019 and held it in 2 quarters. The position peaked at $489K in Q2 2019. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

  • Assenagon Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 5,727 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $432K.
  • Assenagon Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2019 and held it in 2 quarters.
  • Assenagon Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $489K in Q2 2019.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.